PamBio


Public lists: Pharma Startups (4733)

PamBio operates as a biotechnology company that develops drug therapy for acute bleeding conditions. The company's main product is an anti-fibrinolytic agent that is an inactive, mutated Tissue Plasminogen Activator (tPA).

PamBio operates as a biotechnology company that develops drug therapy for acute bleeding conditions. The company's main product is an anti-fibrinolytic agent that is an inactive, mutated Tissue Plasminogen Activator (tPA).

Company (Alive / Active)

Phone: +972 4 6098600

Fax:

P.O. Box 1252

Nazareth, 17111
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
PamBio $7.8M Jul 19, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related PamBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)